Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 795 | 2,436 | 3,540 | 3,896 | 3,970 |
| Operating Income | -795 | -2,436 | -3,540 | -3,896 | -3,970 |
| Other Income | 1 | 2 | 4 | 12 | 12 |
| Pre-tax Income | -794 | -2,434 | -3,536 | -3,884 | -3,958 |
| Net Income Continuous | -794 | -2,434 | -3,536 | -3,884 | -3,958 |
| Net Income | $-794 | $-2,434 | $-3,536 | $-3,884 | $-3,958 |
| EPS Basic Total Ops | -0.03 | -0.09 | -0.13 | -0.15 | -0.15 |
| EPS Basic Continuous Ops | -0.03 | -0.09 | -0.13 | -0.15 | -0.15 |
| EPS Diluted Total Ops | -0.03 | -0.09 | -0.13 | -0.15 | -0.15 |
| EPS Diluted Continuous Ops | -0.03 | -0.09 | -0.13 | -0.15 | -0.15 |
| EBITDA(a) | $-793 | $-2,434 | $-3,538 | $-3,894 | $-3,967 |